Hospital News and Research

RSS

Event to address rheumatoid arthritis

26 men and women with RA from across europe honoured as they share their inspirational stories. Actress, artist and activist Jane Seymour will host the first My Day for RA European event in Barcelona, Spain this evening to recognise the daily challenges, hopes and achievements of people living with rheumatoid arthritis (RA).

22 Sep 2009

Smoking bans result in consistent decline in heart attack rates: Study

A consistent decline in heart attack rates following the implementation of smoking bansStrongly enforced legislation to restrict smoking produces rapid and substantial reductions in community rates of heart attack, according to a meta-analysis published today in Circulation, the journal of the American Heart Association.

22 Sep 2009

Late diagnosis of bipolar disorder in children and adults

75% of the cases of paediatric bipolar disorder are diagnosed late - up to 18 months - due to the symptoms manifesting themselves in a different manner depending on whether the patient is a child or adult. Moreover, 25% of sufferers have a delay in their medical diagnoses of up to three years and four months, according to a study by the Department of Psychiatry and Medical Psychology at the University Hospital of Navarra, in collaboration with the Paediatric Psychopharmacology Unit at the l Massachusetts General Hospital at Harvard University (Boston, United States).

22 Sep 2009

Researchers to present results of HORIZONS-AMI trial at TCT scientific symposium

Two subset analyses from the landmark HORIZONS-AMI trial show that the anticoagulant bivalirudin lowers major bleeding and cardiac death versus the combination of heparin and a GP IIb/IIIa inhibitor in patients with ST-segment myocardial infarction (STEMI) who have disease of the left anterior descending artery (LAD), while in STEMI patients at highest risk for death, bivalirudin also confers the greatest mortality benefit.

22 Sep 2009

Sentillion to participate in National Health IT Week's Technology Showcase

As part of their efforts to improve the effectiveness of both security and clinical workflows in the healthcare delivery process, Sentillion, whose identity and access management (IAM) solutions are the most widely implemented in healthcare, today announced their participation in the “Steering Committee on Telehealth and Healthcare Informatics” Healthcare Information Technology Showcase on Thursday, September 24th on Capitol Hill. The Technology Showcase is part of the activities of “National Health IT Week” going on September 21st – 25th in Washington DC.

22 Sep 2009

IRSF announces funding of new clinical study with disease-modifying therapy treatment for Rett syndrome

Today, the International Rett Syndrome Foundation announced that it will provide $200,000 in 2009 to support a newly proposed clinical trial with a growth-factor based treatment for Rett Syndrome. The study will be carried out by a team of clinical trials specialists at the Boston Children's Hospital, led by Dr. Omar Khwaja MD, PhD and will be the first potentially disease modifying therapy ever to be tested in Rett syndrome patients.

22 Sep 2009

Major shift in cancer research priorities needed

Cancer research is too focused on new drug development, while not enough money and effort is being devoted to pursuing important advances in knowledge likely to have the biggest impact on combating the disease in the next few decades, a leading research policy expert says, adding that a major shift in research priorities will be crucial to the ability to cope with the coming wave of cancer cases.

22 Sep 2009

Drug-eluting stents effective for diabetic patients

Results of a multicenter study in Asia, demonstrating that drug-eluting stents are effective with a low rate of complications in diabetic patients, will be presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).

22 Sep 2009

Technique to reduce stroke in cardiac surgery patients

Sequoia Hospital announced today that they are one of only two hospital participant abstracts selected for oral presentation at the Society of Thoracic Surgeons Advances in Outcomes and Quality national conference held this week in San Diego, California. "Separated Cerebral and Corporeal Perfusion Reduces Stroke Risk in Cardiac Surgery Patients with Mobile Aortic Atheromata" will be presented by Audrey Fisher, MPH, Sequoia Hospital Manager of Cardiovascular Quality & Outcomes. This new technique was developed to reduce strokes in cardiac surgery patients by isolating blood flow to the brain during cardiopulmonary bypass.

22 Sep 2009

HTA acquires GHS medical office building portfolio

Healthcare Trust of America, Inc., (the "REIT"), a self-managed non-traded real estate investment trust, announced the completed acquisition of a 16-building portfolio from Greenville Hospital System ("GHS") based in Greenville, South Carolina for approximately $162,820,000 on September 18, 2009.

22 Sep 2009

Health Robotics chooses Device Technologies Australia as its exclusive CytoCare partner for Oceania

Health Robotics today announced that it has signed an exclusive five-year strategic partnership with Device Technologies Australia Pty Ltd. for its revolutionary CytoCare(TM) Robot. This strategic agreement enables Device Technologies Australia to achieve its goal of safely, accurately and cost-effectively automating the preparation of Oncology I.V. Admixtures to complement its other market-leading Oncology and Surgery Robotic solutions.

22 Sep 2009

KYPHON Cement Delivery System from Medtronic

Medtronic, Inc. (NYSE:MDT), today announced the full U.S. launch of the KYPHON Cement Delivery System (CDS), adding an innovative bone cement delivery option to its extensive KYPHON Balloon Kyphoplasty product portfolio for the treatment of vertebral compression fractures (VCFs).

22 Sep 2009

AAA Assurance Corporation of Vietnam and International Medical Group sign historic agreement

International Medical Group®, Inc. (IMG®), a worldwide leader in designing, distributing and administering global health care benefits, signed a historic agreement in Ho Chi Minh City with the joint stock company, AAA Assurance Corporation of Vietnam.

22 Sep 2009

Winners of "Passion & Results" Award announced by Instrumentation Laboratory

Instrumentation Laboratory (IL) today announced the three recipients of their "Passion & Results" Award. The winners were presented with their awards by IL during ceremonies at the Congress for the International Society on Thrombosis and Haemostasis (ISTH) held in Boston, MA, July 11-16 and at the Annual Meeting for the American Association for Clinical Chemistry (AACC), in Chicago, IL, July 19-23.

22 Sep 2009

Amgen announces Phase 3 results evaluating Vectibix in combination with FOLFIRI chemotherapy

Amgen (Nasdaq: AMGN) today announced detailed results from the Phase 3 '181' trial evaluating Vectibix((R)) (panitumumab) in combination with FOLFIRI (an irinotecan based chemotherapy), as a second-line treatment for metastatic colorectal cancer (mCRC). In this trial, Vectibix significantly improved progression-free survival (PFS) in patients with KRAS wild-type mCRC.

22 Sep 2009

Barbershop singing helps cancer-survivor

For Marguerite Paustenbach, her secret weapon in the fight against breast cancer turned out to be her strong faith and love for barbershop singing. Paustenbach is a member of Village Vocal Chords, a Chicago-based barbershop singing group that’s part of Harmony, Inc., an all women’s barbershop singing organization currently celebrating its 50th anniversary.

22 Sep 2009

PeriGen’s protocol bundle to prevent H1N1 in pregnant women

PeriGen, Inc., today announced the release of its Influenza Prevention and Treatment Bundle to its North American client hospitals. In advance of the approaching flu season, PeriGen’s protocol bundle will help clinicians follow recommended guidelines for screening, preventing and treating as well as accurately reporting cases of seasonal flu and H1N1 (“Swine Flu”) to state and local officials.

22 Sep 2009

Bayer's regorafenib showed 50% stabilization rate in RCC patients

Bayer today announced results from a Phase II trial of regorafenib (BAY 73-4506), a potent oral multi-kinase inhibitor, which demonstrated that treatment with regorafenib resulted in a 31 percent partial response rate and 50 percent stabilization rate in patients with metastatic renal cell carcinoma (RCC).

22 Sep 2009

T-M-Partners chooses InterSystems Ensemble for its CMS Quality Manager healthcare application

InterSystems Corporation today announced that Technology Medical Partners (T-M-Partners) has selected the InterSystems Ensemble® rapid integration and development platform for its CMS Quality Manager healthcare application. The first of many healthcare technology solutions under development by T-M-Partners, CMS Quality Manager is designed to vastly improve the data abstraction and administrative processes of reporting core measures to the Centers for Medicaid and Medicare Services (CMS).

22 Sep 2009

Mild exercises for the bed-bound patients helps to combat muscle wasting

Critical care experts at Johns Hopkins are reporting initial success in boosting recovery and combating muscle wasting among critically ill, mostly bed-bound patients using any one of a trio of mild physical therapy exercises during their stays in the intensive care unit (ICU).

22 Sep 2009